Interaction of Na2B12H11SH with liposomes:: Influence on zeta potential and particle size

被引：18

作者：

Awad, D ^{[1
]}

Tabod, I

Lutz, S

Wessolowski, H

Gabel, D

机构：

[1] Univ Bremen, Dept Chem, D-28334 Bremen, Germany

[2] Univ Bremen, Inst Environm Proc Engn, D-28334 Bremen, Germany

来源：

JOURNAL OF ORGANOMETALLIC CHEMISTRY | 2005年 / 690卷 / 11期

关键词：

BSH; liposomes; liposome size; zeta potential;

D O I：

10.1016/j.jorganchem.2005.01.013

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

The interaction of Na2B12H11SH (BSH) with liposomes has been studied. BSH is a compound used clinically in boron neutron capture therapy of glioblastoma, and is known to enter tumor cells. Liposomes were used as a model for studying the interaction of BSH with cell membranes. BSH led to changes in the zeta potential of liposomes consisting of DODAB (dioctadecyldimethylammonium bromide) alone or with DOPC (dioleylphosphatidylcholine) or DOPE (dioleylphosphatidylethanolamine). It also led to changes of the size of DODAB liposomes, with a maximum size at small zeta potentials. A firm binding of BSH with the head groups of the lipid must be assumed. (c) 2005 Elsevier B.V. All rights reserved.

引用

页码：2732 / 2735

页数：4

共 50 条

[31] Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture - Comments
Reulen, H
ACTA NEUROCHIRURGICA, 1997, 139 (07) : 611 - 612
[32] CLINICAL PHASE-I STUDY OF NA2B12H11SH (BSH) IN PATIENTS WITH MALIGNANT GLIOMA AS PRECONDITION FOR BORON NEUTRON-CAPTURE THERAPY (BNCT)
HARITZ, D
GABEL, D
HUISKAMP, R
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (05): : 1175 - 1181
[33] Na2B11H13 and Na11(B11H14)3(B11H13)4 as potential solid-state electrolytes for Na-ion batteries
Souza, Diego H. P.
D'Angelo, Anita M.
Humphries, Terry D.
Buckley, Craig E.
Paskevicius, Mark
DALTON TRANSACTIONS, 2022, 51 (36) : 13848 - 13857
[34] DISTRIBUTION OF BORON IN 2 (B12H11SH)2--INFUSED PATIENTS WITH MALIGNANT GLIOMA
SLATKIN, DN
FINKEL, GC
MICCA, PL
LASTER, BH
POLETTI, CE
SWEET, WH
STRAHLENTHERAPIE UND ONKOLOGIE, 1989, 165 (2-3): : 224 - 246
[35] Efficient direct fluorination of the B12H11(NH3)- anion in acetonitrile and comparison of the structures of Na(H2O)4(B12F11(NH3)), Na(H3O) (H2O)3(B12F12), and Na2(H2O)4(B12F12)
Bukovsky, Eric V.
Pluntze, Amanda M.
Strauss, Steven H.
JOURNAL OF FLUORINE CHEMISTRY, 2017, 203 : 90 - 98
[36] Anion Packing and Cation Mobility in Potential Solid Electrolytes Na2B12H12-xIx and (A1A2 )B12H12 (A1 = Li, Na, A2 = Li, Na, K, Cs)
Sadikin, Yolanda
Schouwink, Pascal
Brighi, Matteo
Cerny, Radovan
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2016, 72 : S290 - S290
[37] BIOLOGICAL EFFICACY OF THERMAL-NEUTRONS USING NA2B-10(12)H11SH STUDIED INVIVO ON B-16 MOUSE MELANOMA
SPRYSHKOVA, R
NAIDENOV, M
BORISOV, G
KOMKOV, M
BRATSEV, V
SEREBRYAKOV, N
DEMIDOV, A
STRAHLENTHERAPIE UND ONKOLOGIE, 1989, 165 (2-3): : 213 - 215
[38] NEW SYNTHETIC ROUTES TO UNDECAHYDROMERCAPTO-CLOSO-DODECABORATE(2-),B12H11SH2-
TOLPIN, EI
WELLUM, GR
BERLEY, SA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1977, 173 (MAR20): : 43 - 43
[39] Membrane binding of Na2B12H1SH (BSH) with phosphatidylcholine in boron neutron capture therapy
Kageji, T
Nagahiro, S
Matsumoto, K
Otersen, B
Gabel, D
Nakagawa, Y
FRONTIERS IN NEUTRON CAPTURE THERAPY, VOLS 1 AND 2, 2001, : 1039 - 1044
[40] The anionic boron cluster (B12H11SH)2- as a means to trigger release of liposome contents
Gabel, Detlef
Awad, Doaa
Schaffran, Tanja
Radovan, Diana
Daraban, Daniel
Damian, Luminita
Winterhalter, Mathias
Karlsson, Goran
Edwards, Katarina
CHEMMEDCHEM, 2007, 2 (01) : 51 - 53

← 1 2 3 4 5 →